MaxCyte Leadership
Maher Masoud
President and Chief Executive Officer
Mr. Masoud was named President and Chief Executive Officer of MaxCyte in January of 2024. He brings more than 25 years of experience in the biopharmaceutical industry, including 17 years as an attorney and general counsel, to his new role at MaxCyte. Mr. Masoud has most recently served as Executive Vice President, Head of Global Business Development, and Chief Counsel at MaxCyte. During his tenure, MaxCyte’s strategic platform license (SPL) partnerships grew to include 29 partners (as of September 2024).
Mr. Masoud started his biopharmaceutical career as a research associate with Glen Research, a Maravai company, before joining Human Genome Sciences as Director and Corporate Counsel, overseeing legal activities for the company’s global clinical trials, until its acquisition by GlaxoSmithKline. Prior to joining MaxCyte, he oversaw the operations of six business subsidiaries at Wellstat, a life science holding company. During his tenure at Human Genome Sciences and Wellstat, Mr. Masoud supported the launch of three FDA approved therapies, Benlysta®, Vistogard® and Xuriden®.
Mr. Masoud earned his Juris Doctor degree from Michigan State University College of Law after completing his Bachelor of Science degree in cell and molecular biology genetics at the University of Maryland.
Maher Masoud
President and Chief Executive Officer
Parmeet Ahuja
Chief Financial Officer
Mr. Ahuja brings over 20 years of finance leadership experience across a global, publicly traded, life sciences organization, most recently serving as Vice President, Investor Relations at Agilent Technologies, where he worked closely with senior leadership to help shape and communicate the company’s narrative to analysts and investors. Previously, he held several leadership roles at Agilent in operational finance, financial planning and analysis, enterprise audit and controls, and global financial operations. Mr. Ahuja holds an MBA in Finance from San Jose State University and a Bachelor of Commerce in Accounting from Delhi University.
Parmeet Ahuja
Chief Financial Officer
Ana-Paula Martins Fernandes
Senior Vice President, Global Sales
Ms. Fernandes has over 30 years of global commercial leadership and general management experience in the life sciences industry. She has launched and scaled businesses across multiple continents, introducing disruptive tools that have advanced research, diagnostics, and treatment - leading to new diagnostics tests, drug targets, and novel therapies. Before joining MaxCyte, she held senior leadership roles at Azenta Life Sciences, Roche Diagnostics, Precision NanoSystems (now Cytiva), Mettler-Toledo Rainin, and Life Technologies (Applied Biosystems/Thermo Fisher Scientific). With expertise in building high-performing teams and developing go-to-market strategies, she has driven commercial growth through data-driven and eCommerce business models.
Ms. Fernandes excels in strategic turnarounds, operational excellence, and customer-centric execution. She holds an MBA from Fundação Getulio Vargas (FGV) and a B.S. in Business Administration from Universidade Paulista (UNIP).
Ana-Paula Martins Fernandes
Senior Vice President of Global Sales
Jack Horgan
Senior Vice President of Corporate Development
Mr. Horgan is an experienced corporate development and strategy leader that has spent his career supporting organizations in strategy development, mergers and acquisitions, strategic commercial and research collaborations and other growth initiatives. He most recently held an operating role at CSafe Global. Prior to that, he held various corporate development and strategy roles at Sigma-Aldrich and its successor company, MilliporeSigma. He began his career at PwC in audit and due diligence consulting.
Mr. Horgan is a certified public accountant. He received a Master of Business Administration from the Kellogg School of Management at Northwestern University in Chicago.
Jack Horgan
Senior Vice President of Corporate Development
Jay Gelfman
Chief Operations Officer
Jay Gelfman serves as the Chief Operations Officer at MaxCyte, where he drives operational strategy and organizational scaling to support the company’s expanding global growth. With executive oversight across manufacturing, supply chain, information technology, project management, and off-target assay lab operations, Jay has been instrumental in optimizing these critical functions for sustained growth. A seasoned leader with over 25 years of experience, he has a proven track record of guiding life sciences organizations through successful business transformations and complex mergers and acquisitions.
Prior to MaxCyte, Jay held positions of increasing responsibility at Innate Pharma, AstraZeneca, and MedImmune. He holds an MBA in Finance and Information Systems from the University of Maryland’s Robert H. Smith School of Business and a BS in Finance from the Smeal College of Business at Penn State University.
Jay Gelfman
Chief Operations Officer
Jill Mayer
Senior Vice President of Human Resources
Ms. Mayer has more than 20 years of broad, cross-industry human resources leadership experience. With a passion for people, she has developed comprehensive human resources programs and partnered with leaders in both public and private companies to build strong, engaged organizations and teams. Previously, she served in various human resources leadership roles at Fluke Networks, EntreMed, the American Chemical Society and Peak Technologies.
Ms. Mayer holds a master’s degree in psychology from the University of Delaware as well as a bachelor’s degree in psychology from the University of Pennsylvania.
Jill Mayer
Senior Vice President of Human Resources
